Reactivity between herpesvirus type 2-related soluble cervical tumor cell membrane antigens and matched cancer and control sera.
D000818:Animals; D000914:Antibodies, Viral / Q000302:isolation & purification; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm / Q000302:isolation & purification*; D000956:Antigens, Viral / Q000302:isolation & purification; D002460:Cell Line; D002462:Cell Membrane / Q000276:immunology*; D002986:Clinical Trials as Topic; D003168:Complement Fixation Tests; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006168:Guinea Pigs / Q000276:immunology; D006564:Herpesviridae / Q000276:immunology*; D006801:Humans; D007106:Immune Sera; D007668:Kidney / Q000196:embryology; D008722:Methods; D008875:Middle Aged; D010298:Parity; D002583:Uterine Cervical Neoplasms / Q000276:immunology*; D014625:Vaginal Neoplasms / Q000276:immunology; D014846:Vulvar Neoplasms / Q000276:immunology
D000914:Antibodies, Viral; D000951:Antigens, Neoplasm; D000956:Antigens, Viral; D007106:Immune Sera